JP2003171305A - Ameliorating therapeutic agent for diabetes - Google Patents
Ameliorating therapeutic agent for diabetesInfo
- Publication number
- JP2003171305A JP2003171305A JP2001366862A JP2001366862A JP2003171305A JP 2003171305 A JP2003171305 A JP 2003171305A JP 2001366862 A JP2001366862 A JP 2001366862A JP 2001366862 A JP2001366862 A JP 2001366862A JP 2003171305 A JP2003171305 A JP 2003171305A
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- tea leaves
- leaves
- diabetes
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、マメ科に属するア
スパラサス・リネアリスと景天科に属する石蓮花の茶葉
を含む糖尿病改善治療剤に関する。TECHNICAL FIELD The present invention relates to a therapeutic agent for diabetes mellitus containing tea leaves of Aspalathus linearis belonging to the family Leguminaceae and stone of Lotus lotus belonging to the scenic family.
【0002】[0002]
【従来の技術】自己免疫疾患である糖尿病は、近年、中
年者や高年者だけでなく若年者で罹患する者が増加して
きている。また、糖尿病は三大成人病の一つともいわ
れ、治療が困難で完治することが難しく、有効な薬剤の
開発が要望されている。糖尿病の治療には薬剤を長期的
に服用しなくてはならないので、副作用が少ない天然物
を原料とするのが望ましく、また、日常的に簡便に摂取
できるものでなくてはならない。2. Description of the Related Art In recent years, diabetes, which is an autoimmune disease, has been increasing in young people as well as middle-aged and elderly people. Also, diabetes is said to be one of the three major adult diseases, and it is difficult to cure it and it is difficult to completely cure it. Therefore, there is a demand for the development of an effective drug. Since a drug must be taken for a long period of time to treat diabetes, it is desirable to use a natural product with few side effects as a raw material, and it must be one that can be ingested easily on a daily basis.
【0003】さらに、糖尿病にはインシュリン投与によ
って治療効果の上がるインシュリン依存型糖尿病と、イ
ンシュリン投与で治療効果の現れない非インシュリン依
存型糖尿病がある。非インシュリン依存型糖尿病に対し
ては、注射等によらない経口摂取によって糖尿病を安定
化させる改善治療剤の開発が要望されている。非インシ
ュリン依存型糖尿病に対し、マメ科植物のアスパラサス
・リネアリス抽出物が改善効果を有することが見いださ
れている。(特開平5−246875号公報参照)[0003] Furthermore, diabetes includes insulin-dependent diabetes mellitus whose therapeutic effect is improved by insulin administration, and non-insulin-dependent diabetes mellitus which does not show a therapeutic effect by insulin administration. For non-insulin dependent diabetes mellitus, development of an improved therapeutic agent for stabilizing diabetes by oral ingestion without injection or the like has been demanded. It has been found that an Asparagus linealis extract of legumes has an improving effect on non-insulin dependent diabetes mellitus. (See Japanese Patent Laid-Open No. 5-246875)
【0004】その他にも非インシュリン依存型糖尿病治
療用新薬と漢方薬が開発されたが、投与量が大きいか長
期使用に見られる抗薬性或いは副作用があり、また血糖
値降下効果が良くても低血糖になりやすい等の欠点があ
る。In addition, new drugs for treating non-insulin-dependent diabetes mellitus and Chinese herbs have been developed. However, they have a large dose or have an anti-drug or side effect seen in long-term use. There are drawbacks such as easy blood sugar.
【0005】[0005]
【発明が解決しようとする課題】アスパラサス・リネア
リス抽出物は天然成分で、副作用がなく、簡便に摂取で
きる利点があるが、さらに、糖尿病治療効果を高め、簡
便に摂取できるようにすることが本発明の課題である。[Problems to be Solved by the Invention] Asparasus linearias extract is a natural ingredient and has the advantage that it has no side effects and can be easily taken. It is an object of the present invention.
【0006】[0006]
【課題を解決するための手段】本発明は、アスパラサス
・リネアリスの茶葉に景天科に属する石蓮花の茶葉を混
合して使用することで、この課題を解決した。すなわ
ち、アスパラサス・リネアリスを単独で使用するより、
優れた糖尿病治療効果が見いだされた。また、混合した
茶葉をそのまま湯で抽出して使用することができるので
日常生活において簡便に摂取することができる。The present invention has solved this problem by mixing the tea leaves of Aspalathus linealis with the tea leaves of the stone lotus belonging to the Jingten family. That is, rather than using Aspalathus linealis alone,
An excellent therapeutic effect on diabetes was found. Further, the mixed tea leaves can be extracted as they are from hot water and used, so that they can be easily ingested in daily life.
【0007】アスパラサス・リネアリスと石蓮花の茶葉
の混合物、また、これらの粉砕物の混合物を、通常の日
本茶、中国茶、紅茶などと同様に湯または水で抽出して
飲用するものである。[0007] A mixture of Aspalathus linealis and Shirenbana tea leaves, or a mixture of these pulverized products is extracted with hot water or water in the same manner as ordinary Japanese tea, Chinese tea, black tea, etc. and is then drunk. .
【0008】水で抽出する場合には、アスパラサス・リ
ネアリスと石蓮花の茶葉の混合茶葉の50〜1000倍
の水を加え、5〜30分程度沸騰抽出するのが好まし
い。また、緑茶と同様の方法で抽出するときは、80〜
100度の湯を用い、アスパラサス・リネアリスと石蓮
花の混合茶葉の50〜500倍の湯に1〜30分浸漬し
て抽出液を得る。In the case of extraction with water, it is preferable to add 50 to 1000 times as much water as the mixed tea leaves of Aspalathus linealis and Sekirenhana tea leaves, and carry out boiling extraction for about 5 to 30 minutes. Also, when extracting by the same method as green tea,
Using 100 degree hot water, the extract is obtained by immersing in 50 to 500 times hot water of mixed tea leaves of Aspalathus linealis and stone lotus for 1 to 30 minutes.
【0009】また、アスパラサス・リネアリス茶葉と石
蓮花茶葉そのものを凍結乾燥して粉砕し、粉末化して水
またはお湯に溶かしたり、または、粉末顆粒、錠剤、ゼ
リーなど任意の形態にすることが可能である。[0009] Also, Aspalathus linealis tea leaves and stone lotus tea leaves themselves are freeze-dried and crushed, powdered and dissolved in water or hot water, or in any form such as powder granules, tablets and jelly. Is.
【0010】摂取量は、糖尿病の程度により異なるが、
常用する場合には、一日当たりアスパラサス・リネアリ
ス茶葉2gと石蓮花茶葉1gを混合した乾燥葉に対し1
00ミリリットル〜1500ミリリットルの湯または水
で抽出した液を飲用するのが好ましい。The amount of intake varies depending on the degree of diabetes,
In the case of regular use, it is 1 for dried leaves obtained by mixing 2g of Aspalathus linealis tea leaves and 1g of stone lotus tea leaves per day.
It is preferable to drink a liquid extracted with 00 ml to 1500 ml of hot water or water.
【0011】アスパラサス・リネアリスと石蓮花の混合
物は、ラットに対する急性毒性試験で死亡例は皆無であ
り、生化学血液検査および病理組織学的検査においても
異常が認められなかった。The mixture of Aspalathus linealis and stone lotus showed no death in an acute toxicity test in rats, and no abnormality was observed in biochemical blood tests and histopathological tests.
【0012】[0012]
【実施例】製造例
アスパラサス・リネアリスの葉・茎と石蓮花の葉の2:
1(重量)の混合物を、5mm長に切断後、ローリン
グ、酵素醗酵、天日乾燥の工程を経て乾燥葉とする。乾
燥葉4gを水1.5リットルで常温から加熱し、15分
間沸騰させ抽出液を得た。[Examples] Production example Aspalathus linealis leaves / stems and stone lotus leaves 2:
The 1 (weight) mixture is cut into a length of 5 mm, and then rolled, subjected to enzyme fermentation, and dried in the sun to be dried leaves. 4 g of dried leaves were heated from room temperature with 1.5 liters of water and boiled for 15 minutes to obtain an extract.
【0013】製造例で得た抽出液を表1に示した糖尿病
患者に1日600ミリリットルから1200ミリリット
ル飲用させて症状の改善を調べた。6ヶ月間飲用後の結
果を表1に示す。男性患者は45〜70歳であり、女性
患者は55〜75歳である。性別、年齢を問わず尿中の
糖の降下が確認された。The extract obtained in the production example was administered to diabetic patients shown in Table 1 in an amount of 600 ml to 1200 ml per day to examine improvement of symptoms. Table 1 shows the results after drinking for 6 months. Male patients are 45-70 years old and female patients are 55-75 years old. A decrease in urinary glucose was confirmed regardless of sex or age.
【0014】[0014]
【表1】 [Table 1]
【0015】[0015]
【発明の効果】アスパラサス・リネアリスに石蓮花の茶
葉を混合して摂取することにより、アスパラサス・リネ
アリスを単独で摂取するよりも、糖尿病に対しさらに高
い改善効果がある。また、緑茶などの茶葉と同様に使用
することができるので簡便であり、毎日摂取するのが容
易である。これにより、今まで治療の困難だった糖尿病
の疾患を副作用無く確実に改善治療することができる。[Effects of the Invention] By ingesting Aspalathus linealis mixed with the tea leaves of stone lotus, it has a higher effect of improving diabetes compared with ingesting Aspalathus linealis alone. Further, since it can be used in the same manner as tea leaves such as green tea, it is convenient and easy to take daily. This makes it possible to surely improve and treat diabetic diseases, which have been difficult to treat until now, without causing side effects.
Claims (3)
の茶葉を混合した糖尿病改善治療剤。1. A therapeutic agent for diabetes mellitus, which comprises a mixture of tea leaves of Aspalathus linealis and tea leaves of Lotus Lotus flower.
リスの茶葉と石蓮花の茶葉の混合比は重量で2対1であ
る糖尿病改善治療剤。2. The therapeutic agent for diabetes mellitus according to claim 1, wherein the mixing ratio of the tea leaves of Aspalathus linealis and the tea leaves of stone lotus flower is 2 to 1 by weight.
たものである糖尿病改善治療剤。3. The therapeutic agent for diabetes mellitus according to claim 1 or 2, wherein the tea leaves are ground.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001366862A JP2003171305A (en) | 2001-11-30 | 2001-11-30 | Ameliorating therapeutic agent for diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001366862A JP2003171305A (en) | 2001-11-30 | 2001-11-30 | Ameliorating therapeutic agent for diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003171305A true JP2003171305A (en) | 2003-06-20 |
Family
ID=19176699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001366862A Pending JP2003171305A (en) | 2001-11-30 | 2001-11-30 | Ameliorating therapeutic agent for diabetes |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2003171305A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1923066A1 (en) * | 2006-11-08 | 2008-05-21 | Cognis IP Management GmbH | Composition comprising rooibos tea and conjugated linoleic acid (CLA) |
WO2008110551A1 (en) | 2007-03-12 | 2008-09-18 | Zadec Aps | An anti-diabetic extract of rooibos |
JP2009501197A (en) * | 2005-07-15 | 2009-01-15 | ラボラトワール セローノ ソシエテ アノニム | Glepp-1 inhibitor in the treatment of autoimmune diseases and / or inflammatory diseases |
JP2020132589A (en) * | 2019-02-21 | 2020-08-31 | 直久 石川 | Neuronal cell death inhibitor and food composition for neuronal cell death inhibition |
-
2001
- 2001-11-30 JP JP2001366862A patent/JP2003171305A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009501197A (en) * | 2005-07-15 | 2009-01-15 | ラボラトワール セローノ ソシエテ アノニム | Glepp-1 inhibitor in the treatment of autoimmune diseases and / or inflammatory diseases |
EP1923066A1 (en) * | 2006-11-08 | 2008-05-21 | Cognis IP Management GmbH | Composition comprising rooibos tea and conjugated linoleic acid (CLA) |
WO2008110551A1 (en) | 2007-03-12 | 2008-09-18 | Zadec Aps | An anti-diabetic extract of rooibos |
EP2368560A1 (en) * | 2007-03-12 | 2011-09-28 | Zadec ApS | An anti-diabetic extract of rooibos |
US20110275579A1 (en) * | 2007-03-12 | 2011-11-10 | Zadec Aps | Anti-diabetic extract of rooibos |
US8877717B2 (en) | 2007-03-12 | 2014-11-04 | Zadec Aps | Anti-diabetic extract of rooibos |
JP2020132589A (en) * | 2019-02-21 | 2020-08-31 | 直久 石川 | Neuronal cell death inhibitor and food composition for neuronal cell death inhibition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103041118B (en) | Composition with effects of reducing blood sugar and reducing blood lipid | |
CN104068284A (en) | Compound feed used for curing gosling plague and preparation method of compound feed | |
CN103932173A (en) | Composition for dispelling alcohol effect and protecting liver | |
JP5928732B2 (en) | Brown adipocyte activator | |
CN103719491A (en) | Rhizoma polygonati health-care tea for invigorating spleen and moistening lung and preparation method thereof | |
JP2003171305A (en) | Ameliorating therapeutic agent for diabetes | |
KR101923603B1 (en) | A composition for anti-obesity comprising green tea complex extracts | |
CN103893593B (en) | Pharmaceutical composition with effects of clearing away heat and toxic materials, resisting inflammations and boosting immunity | |
CN103948021B (en) | A kind of Flos Chrysanthemi eyesight-improving health care function granule and production method thereof | |
CN106727902B (en) | Cordyceps sinensis-containing traditional Chinese medicine composition for dispelling effects of alcohol and protecting liver and application thereof | |
CN112807362B (en) | Traditional Chinese medicine composition for treating subacute thyroiditis in acute stage and preparation method and application thereof | |
KR20040101598A (en) | Active fraction having weight loss effects on Leprdb/Leprdb mice isolated from medicinal plants | |
CN108419869A (en) | Fiery composition, beverage and preparation method thereof under a kind of heat-clearing toxin expelling | |
KR102456193B1 (en) | Sleep inducing tea containing l-theanine | |
CN100560110C (en) | A kind of compound Chinese medicinal preparation for the treatment of damage | |
KR20130041494A (en) | The composition for treating diabetes | |
CN101693086B (en) | Traditional Chinese medicine compound preparation for preventing recurrent aphthae, preparation method and application thereof | |
CN112043789A (en) | Composition for preventing or treating nicotine addiction comprising extract of liriope platyphylla as active ingredient | |
CN102727663A (en) | Application of Pu'er tea extract in preparing hypotensive medicine or foodstuff | |
CN104474103A (en) | Natural plant hypoglycemic agent and preparation method thereof | |
US20050175716A1 (en) | Method and herbal composition for treatment of diabetes | |
CN104623097A (en) | Application of Pu'er tea extract in preparation of fat reducing medicines or health foods | |
CN112755123B (en) | Traditional Chinese medicine composition for relieving asthenopia, preparation method and application thereof | |
CN108143756A (en) | A kind of plant hypoglycemic agent and preparation method thereof | |
CN108125237A (en) | A kind of anti-inflammatory health products of kobadrin and its preparation process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041027 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080729 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080925 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081021 |